Alessandro Corso
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 83
- Multiple Myeloma Research and Treatments 75
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 6
-
- Protein Degradation and Inhibitors 19
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
- Co-authors
- Mario Lazzarino (42 shared papers)Silvia Mangiacavalli (41 shared papers)Marzia Varettoni (27 shared papers)Patrizia Zappasodi (30 shared papers)Meletios Α. Dimopoulos (9 shared papers)H. Miles Prince (2 shared papers)Marta Olesnyckyj (3 shared papers)Robert Knight (3 shared papers)
- Journals
- Blood (20 papers)Annals of Hematology (11 papers)Cancer (5 papers)Leukemia Research (4 papers)British Journal of Haematology (4 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Alessandro Corso
106 papers receiving 3.2k citations
Alessandro Corso's Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 2.3k
- Genetics 609
- Oncology 1.3k
- Pathology and Forensic Medicine 360
- Molecular Biology 1.4k
Countries citing papers authored by Alessandro Corso
This map shows the geographic impact of Alessandro Corso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Corso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Corso more than expected).
Fields of papers citing papers by Alessandro Corso
This network shows the impact of papers produced by Alessandro Corso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Corso. The network helps show where Alessandro Corso may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Corso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2007 | 1076 |
| 2 | 2009 | 332 | |
| 3 | 2013 | 221 | |
| 4 | 2007 | 85 | |
| 5 | 2010 | 82 | |
| 6 | 2008 | 80 | |
| 7 | 2008 | 70 | |
| 8 | 2009 | 70 | |
| 9 | 2017 | 60 | |
| 10 | 2004 | 58 | |
| 11 | 2005 | 52 | |
| 12 | 1993 | 44 | |
| 13 | Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. | 1998 | 42 |
| 14 | 2015 | 42 | |
| 15 | 2020 | 41 | |
| 16 | 2016 | 40 | |
| 17 | 2019 | 36 | |
| 18 | Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients. | 2001 | 35 |
| 19 | 1999 | 34 | |
| 20 | 2011 | 31 |
About Alessandro Corso
Alessandro Corso is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 112 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (75 papers), Cancer Treatment and Pharmacology (21 papers), Protein Degradation and Inhibitors (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (609 citations), Oncology (1.3k citations), Pathology and Forensic Medicine (360 citations) and Molecular Biology (1.4k citations). Alessandro Corso has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Mario Lazzarino, Silvia Mangiacavalli, Marzia Varettoni, Patrizia Zappasodi, Meletios Α. Dimopoulos, H. Miles Prince, Marta Olesnyckyj, Robert Knight, Gian-Matteo Pica and Zhinuan Yu. Their work appears in journals such as Blood, Annals of Hematology, Cancer, Leukemia Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.